Old Web
English
Sign In
Acemap
>
authorDetail
>
Safoa Ado
Safoa Ado
Cetuximab
Poor performance status
Immune system
Pathology
Head and neck cancer
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical and immune effects of cetuximab and weekly low dose carboplatin and paclitaxel in head and neck cancer patients with poor performance status.
2018
Journal of Clinical Oncology
Marcelo Raul Bonomi
Brett G. Klamer
Tamjeed Ahmed
Safoa Ado
Mitra Kooshki
Jishu Das
Guy N. Brock
Triozzi Pierre
Show All
Source
Cite
Save
Citations (1)
Immune-related saliva micro-RNA’s to predict clinical response to a combination of cetuximab and low-dose chemotherapy in head and neck cancer (HNSCC) patients (pts) with poor performance status (PS).
2017
Journal of Clinical Oncology
Marcelo Raul Bonomi
Safoa Ado
Mitra Kooshki
Tamjeed Ahmed
Christopher A. Sullivan
Joshua D. Waltonen
Pierre L. Triozzi
Show All
Source
Cite
Save
Citations (0)
1